Shiseido’s world’s first discovery of OBP2A present in nose to express in human skin and protect skin from odor particles

As a new mechanism for maintaining the skin’s health and beauty, Shiseido discovered for the first time in the world that OBP2A, an odorant binding protein, contributes to the maintenance of homeostasis in the human epidermis and plays a part in the epidermal barrier.

OBP2A, which is found in the inner part of the human nose, is known to have the function to filter out stress molecules that damage cells.

In the present study, Shiseido revealed that OBP2A is also expressed in the epidermis.

Moreover, the ”French white lily” flower extract was identified as an ingredient that enhances the expression of OBP2A. Shiseido aims to provide solutions that lead to healthy and beautiful skin that can withstand any environment.

Read more

Recent Posts

Final program Cosmetotest on May 14-15, 2025, Preclinical and clinical testing Symposium in Lyon & Hybrid

LIVE & HYBRID All you need to know about preclinical and clinical testing is at…

Save the Date: April 28th, Testing Trends Webinar – Feedback on the Testing and Lab Zone x in-cosmetics global

👉 Register: Exclusive webinar in English April 28th 2025 at 3:00 PM [CEST]   We…

Save the Date: May 8th – What’s trending in cosmetics, A.I and other things! Webinar via Personal Care Insights

HOW AI IS SHAPING BIO-BASED BEAUTY AND PERSONALIZED PRODUCTS 📆 May, 8th 2025 ⏱️ 16:00…